Format

Send to

Choose Destination
Lancet. 2018 Feb 24;391(10122):736. doi: 10.1016/S0140-6736(18)30255-1. Epub 2018 Feb 12.

Hydroxyethyl starch solutions and patient harm.

Author information

1
Clinical Trials Unit, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: ian.roberts@lshtm.ac.uk.
2
Clinical Trials Unit, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
3
University of Melbourne, Melbourne, VIC, Australia.
4
University of Birmingham, Birmingham, UK.
5
Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
6
King's College London, London, UK.
7
Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia; University of New South Wales, Sydney, NSW, Australia.
8
Department of Intensive Care, Rigshospitalet, Copenhagen, Denmark.
9
Jena University Hospital, Jena, Germany; Global Sepsis Alliance, Jena, Germany.
PMID:
29449012
DOI:
10.1016/S0140-6736(18)30255-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center